Keyphrases
α1-adrenoceptor Antagonist
100%
Hypertension Management
100%
Antihypertensive Drugs
100%
Outcome Trials
66%
Alpha-blockers
66%
Cardiac Outcomes
66%
Anglo-Scandinavian
66%
Doxazosin
66%
Tolerability
33%
Heart Failure
33%
Blood Pressure
33%
Beneficial Effects
33%
Heart Attack
33%
Non-associated
33%
Lipid Metabolism
33%
Glucose Metabolism
33%
Plasma Lipids
33%
Add-on Therapy
33%
Metabolic Effects
33%
Uncontrolled Hypertension
33%
Observational Analysis
33%
Gastrointestinal Therapeutic System
33%
Extended-release Formulation
33%
Lipid-lowering Treatment
33%
INIS
data
100%
hypertension
100%
management
100%
lipids
100%
drugs
66%
glucose
33%
reduction
33%
therapy
33%
increasing
33%
risks
33%
availability
33%
metabolism
33%
heart failure
33%
blood pressure
33%
plasma
33%
antihypertensive agents
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antihypertensive Agent
100%
Alpha 1 Adrenergic Receptor Blocking Agent
100%
Alpha Adrenergic Receptor Blocking Agent
66%
Doxazosin
66%
Tolerability
33%
Congestive Heart Failure
33%
Heart Infarction
33%
Add on Therapy
33%
Antihypertensive Drug
33%